YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Sinopharm Group (SEHK:1099) has entered into a mutual NDA with Woori IO to explore noninvasive glucose monitoring techn…
BELLEVUE, Wash., March 19, 2026 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a healthcare-focused holding company advancing innovative medical technologies, today announced that its subsidiary, Woori IO Co., Ltd. ("Woori IO"), has en…
BELLEVUE, WA / ACCESS Newswire / March 19, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a healthcare-focused holding company advancing innovative medical technologies, today announced that its subsidiary, Woori IO Co., Ltd. ("Woori IO"), has e…
As global markets react to political developments and economic indicators, major U.S. indices have reached new highs, driven by optimism around potential trade deals and AI investments. In this dynamic environment, dividend stocks remain a…
In a week marked by record highs for major U.S. stock indexes and mixed sector performances, global markets have been navigating through political developments in Europe and economic data releases in the U.S. With growth stocks outperformi…
In a week marked by fluctuating indices and mixed economic signals, global markets have shown resilience amid busy earnings reports and complex labor market data. As investors navigate these turbulent waters, dividend stocks yielding up to…
As the Hong Kong market experiences a notable upswing, buoyed by China's recent stimulus measures, investors are increasingly looking towards dividend stocks for stable returns amidst this renewed economic optimism. In such an environment,…
As global markets navigate a period of economic adjustments, the Hong Kong market has shown resilience amid broader fluctuations. With the European Central Bank cutting rates and anticipation of similar moves by the U.S. Federal Reserve, i…
As global markets react to economic data and shifts in investor sentiment, the Hong Kong market has shown resilience amid broader uncertainties. With the Hang Seng Index experiencing modest declines, dividend stocks on the SEHK remain a co…
As global markets navigate through mixed economic signals, Hong Kong's market shows resilience, marked by a modest uptick in the Hang Seng Index and robust retail sales growth. In such an environment, dividend stocks in Hong Kong could off…
Exploring the Dividend Sustainability and Growth Prospects of Sinopharm Group Co Ltd (SHTDF) Sinopharm Group Co Ltd (SHTDF) recently announced a dividend of $0.96 per share, payable on 2024-08-13, with the ex-dividend date set for 2024-06-…
As of June 2024, the Hong Kong market faces challenges, notably marked by a 2.84% drop in the Hang Seng Index amidst broader global economic uncertainties and specific regional growth headwinds. This backdrop makes it particularly pertinen…
As global markets navigate through varied economic signals, Hong Kong's stock market has shown resilience, with the Hang Seng Index recently marking a notable uptick. In this context, understanding the appeal of dividend stocks becomes par…
The Hong Kong stock market has recently shown signs of vitality, with a 4.9% uptick in the past week, although it remains 14% lower compared to last year. With earnings projected to grow by 13% annually, investors may find reassurance in s…
Hong Kong stocks fell from a three-week high, led by a retreat in property developers as concerns about debt defaults overshadowed Beijing's efforts to revive home sales and repair market confidence. Sinopharm Group slumped after becoming…
(Reuters) - Pfizer said on Thursday it has signed a strategic cooperation agreement with China's Sinopharm Group, and plans to seek approval to market 12 innovative drugs in China through 2025. Sinopharm's president Liu Yong said during th…
(Adds details from statement, background) BEIJING, Jan 20 (Reuters) - Sinopharm said on Friday its biotech unit has received regulatory approval for clinical trials of its mRNA COVID-19 vaccine targeting the Omicron variant. The unit, base…
(Bloomberg) -- China National Pharmaceutical Group Co. is considering a revived bid for China Traditional Chinese Medicine Holdings Co. that could value the Hong Kong-listed drugmaker at around $4 billion, people with knowledge of the matt…
NEW YORK, Sept 28 (Reuters) - Drugmaker Merck & Co said on Wednesday that it agreed to allow China's Sinopharm to distribute and import its COVID-19 antiviral molnupiravir in China if the drug is approved for use there. The drugmaker said…
By Francesco Guarascio and Panu Wongcha-um BRUSSELS/BANGKOK, Dec 16 (Reuters) - Tens of millions of migrants may be denied COVID-19 vaccines from a global programme because some major manufacturers are worried about legal risks from harmfu…
(Bloomberg) -- In the early days of the Covid-19 vaccine rollout, Chinese shots saved countless lives. They kick-started inoculation programs across Asia, Latin America and the Middle East, while richer countries hoarded scarce mRNA shots…
The Delta variant is an increasing source of concern for health experts as vaccinations wane and the holiday weekend approaches in the U.S. Those at the highest risk are unvaccinated individuals and people living in pockets of states with…
The Delta variant is an increasing source of concern for health experts as vaccinations wane and the holiday weekend approaches in the U.S. Those at the highest risk are unvaccinated individuals and people living in pockets of states with…
Foreign Relations Secretary Marcelo Ebrard said the Mexican government has signed agreements for 12 million doses of the yet-unapproved Sinopharm vaccine and increased to a total of 20 million doses its contracts for the Coronavac dose mad…
For Sinopharm, China’s biggest vaccine developer, coronavirus offers a shot at a future that had been out of reach. Whether Sinopharm can use this as a springboard to roll the vaccine out beyond its vast domestic market, however, depends o…
Experts' fears that people in wealthier countries will be vaccinated before those in poorer nations are coming to fruition. And the inequity could further pressure the global economy, according to a recent study supported by the Internatio…
Experts' fears that people in wealthier countries will be vaccinated before those in poorer nations are coming to fruition. And the inequity could further pressure the global economy, according to a recent study supported by the Internatio…
ASSOCIATED PRESS BEIJING — China has given conditional approval to a coronavirus vaccine developed by state-owned Sinopharm. The vaccine is the first one approved for general use in China. Chen Shifei, the deputy commissioner of China’s Me…
BEIJING, Sept 7 (Reuters) - Shanghai Fosun Pharmaceutical has signed a strategic cooperation agreement with Sinopharm Group to supply a coronavirus vaccine candidate developed by German firm BioNTech, it said on Monday. BioNTech announced…
BEIJING, Sept 7 (Reuters) - Shanghai Fosun Pharmaceutical has signed a strategic cooperation agreement with Sinopharm Group to supply a coronavirus vaccine candidate developed by German firm BioNTech, it said on Monday. BioNTech announced…
RIO DE JANEIRO, July 29 (Reuters) - Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID-19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks, the Brazilian partners sai…
RIO DE JANEIRO, July 29 (Reuters) - Chinese drug company Sinopharm and Parana state have agreed to launch the fourth major COVID-19 vaccine trial in Brazil and will seek regulatory approval in the next two weeks, the Brazilian partners sai…
Sinopharm Group (HKG:1099) has had a rough three months with its share price down 23%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the comp…